Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Join our interdisciplinary faculty of clinicians, statisticians and trial managers with a wealth of RCT experience in this 16th year of the CSM RCT course

This course is ideal for anyone planning or actively involved in RCTs for healthcare evaluation, particularly those early in their career or looking for a refresher course
 Clinical and non-clinical researchers, other professionals allied to medicine, statisticians: all welcome
 Problem-based learning approach mixing lectures & small-group practical work
 Provides a thorough grounding in the principles and practice of all elements of an RCT, rooted in practical experience, the literature and best practice

This year the course is being held at Merton College at the University of Oxford from Monday 17th to Friday 22nd September.

Places are £1450

Enquiries and bookings should be to: +44 (0)1865 223447 or rct.course@csm.ox.ac.uk

Similar stories

IMP-MEL Trial given Green Light to open

OCTRU have now given Green Light approval for IMP MEL to open. This is a phase 1 first-in-human dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC.

WISE opens to recruitment

The WISE Study - Wrist Injury Strengthening Exercise: a randomised multicentre feasibility study of resistance exercise versus usual care for optimising function after distal radius fracture in adults aged 50 years or over has now received OCTRU Green Light approval and has opened to recruitment.

International Clinical Trials Day

Researchers across the world celebrate International Clinical Trials Day today. We have produced a short animation this year to mark the occasion...

Clinical trial finds Azithromycin has no benefit against COVID-19

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.